Orthofix Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	120.28	82.03	83.24	33.11	50.7	87.85
Cash & Short-Term Investments	120.28	82.03	83.24	33.11	50.7	87.85
Cash Growth	107.54%	-1.46%	151.42%	-34.70%	-42.29%	-8.77%
Accounts Receivable	137.78	135.75	134.71	128.1	82.86	78.56
Inventory	177.82	172.32	189.45	222.17	100.15	82.97
Other Current Assets	25.65	26.76	25.88	37.07	22.28	20.14
Total Current Assets	461.52	416.85	433.29	420.44	255.99	269.52
Net Property, Plant & Equipment	125.33	129.4	139.8	159.06	58.23	59.25
Other Intangible Assets	69.34	72.77	98.8	117.49	47.39	52.67
Goodwill	194.93	194.93	194.93	194.93	71.32	71.32
Other Long-Term Assets	35.48	36.7	26.47	33.39	25.71	23.87
Total Assets	886.6	850.65	893.29	925.32	458.63	476.62
Accounts Payable	54.69	58.39	48.8	58.36	27.6	26.46
Current Portion of Long-Term Debt	-	-	-	1.25	-	-
Current Portion of Leases	0.12	0.84	0.76	0.71	0.65	2.59
Other Current Liabilities	106.23	111.25	119.07	104.91	55.37	76.78
Total Current Liabilities	161.03	170.48	168.63	165.22	83.62	105.83
Long-Term Debt	221.34	157.39	157.02	93.11	-	-
Long-Term Leases	12.94	17.06	17.84	18.53	19.24	19.89
Other Long-Term Liabilities	56.11	55.68	46.69	49.72	18.91	13.97
Total Long-Term Liabilities	290.38	230.13	221.54	161.36	38.15	33.86
Total Liabilities	451.42	400.61	390.17	326.59	121.77	139.69
Common Stock	4.04	3.98	3.85	3.72	2.02	1.98
Additional Paid-in Capital	820.25	813.77	779.72	746.45	334.97	313.95
Accumulated Other Comprehensive Income	0.14	0.62	-4.3	-1.29	-1.38	-
Retained Earnings	-389.24	-368.33	-276.14	-150.14	1.25	21
Shareholders' Equity	435.19	450.04	503.12	598.73	336.86	336.93
Total Liabilities & Equity	886.6	850.65	893.29	925.32	458.63	476.62
Total Debt	234.39	175.29	175.61	113.6	19.89	22.48
Net Cash (Debt)	-114.11	-93.26	-92.37	-80.49	30.81	65.37
Net Cash Growth	-	-	-	-	-52.87%	-11.00%
Net Cash Per Share	-2.83	-2.35	-2.42	-2.19	1.53	3.29
Book Value	435.19	450.04	503.12	598.73	336.86	336.93
Book Value Per Share	10.78	11.36	13.19	16.30	16.71	16.99
Tangible Book Value	170.92	182.34	209.39	286.31	218.16	212.95
Tangible Book Value Per Share	4.23	4.60	5.49	7.80	10.82	10.74

SEC Filings: 10-K · 10-Q